The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards?

被引:12
作者
Di Stefano, Michele [1 ]
Quigley, Eamonn M. M. [2 ,3 ]
机构
[1] Univ Pavia, IRCCS S Matteo Hosp Fdn, Dept Internal Med 1, Pavia, Italy
[2] Houston Methodist Hosp, Div Gastroenterol & Hepatol, Lynda K & David M Underwood Ctr Digest Disorders, Houston, TX USA
[3] Weill Cornell Med Coll, Houston, TX USA
关键词
IRRITABLE-BOWEL-SYNDROME; HYDROGEN BREATH TEST; MICROBIOME; PREVALENCE; RIFAXIMIN; METHANE; AXIS;
D O I
10.1111/nmo.13494
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Small intestinal bacterial overgrowth (SIBO) was originally described decades ago as a cause of malabsorption among individuals with abnormal intestinal anatomy and/or impaired gastric acid secretion and intestinal motor functions. More recently, the concept of SIBO has been expanded to explain symptoms among a much broader patient populationa move that brings the definition of SIBO into much sharper focus. For largely logistical reasons, breath tests and, especially, those based on the excretion of hydrogen consequent on the fermentation of unabsorbed carbohydrate substrates, have almost entirely replaced jejunal aspirates in the diagnosis of SIBO. Ever bedeviled by concerns regarding their reliability, hydrogen breath tests have now come under even more critical scrutiny with the study from Sundin and colleagues in this issue suggesting that their sole function is to detect carbohydrate malabsorption and that they are incapable of defining SIBO.
引用
收藏
页数:5
相关论文
共 44 条
[1]   Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea:: A crossover, randomized trial [J].
Attar, A ;
Flourié, B ;
Rambaud, JC ;
Franchisseur, C ;
Ruszniewski, P ;
Bouhnik, Y .
GASTROENTEROLOGY, 1999, 117 (04) :794-797
[2]   Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty? [J].
Aziz, Imran ;
Tornblom, Hans ;
Simren, Magnus .
CURRENT OPINION IN GASTROENTEROLOGY, 2017, 33 (03) :196-202
[3]   New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases [J].
Bajaj, Jasmohan S. ;
Barbara, Giovanni ;
DuPont, Herbert L. ;
Mearin, F. ;
Gasbarrini, Antonio ;
Tack, Jan .
DIGESTIVE AND LIVER DISEASE, 2018, 50 (08) :741-749
[4]   The safety and sensitivity of a telemetric capsule to monitor gastrointestinal hydrogen production in vivo in healthy subjects: a pilot trial comparison to concurrent breath analysis [J].
Berean, Kyle J. ;
Ha, Nam ;
Ou, Jian Zhen ;
Chrimes, Adam F. ;
Grando, Danilla ;
Yao, Chu K. ;
Muir, Jane G. ;
Ward, Stephanie A. ;
Burgell, Rebecca E. ;
Gibson, Peter R. ;
Kalantar-Zadeh, Kourosh .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (06) :646-654
[5]   Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls [J].
Bratten, Jason R. ;
Spanier, Jennifer ;
Jones, Michael P. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (04) :958-963
[6]   Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture [J].
Choung, R. S. ;
Ruff, K. C. ;
Malhotra, A. ;
Herrick, L. ;
Locke, G. R., III ;
Harmsen, W. S. ;
Zinsmeister, A. R. ;
Talley, N. J. ;
Saito, Y. A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (09) :1059-1067
[7]   A clinician's guide to microbiome analysis (vol 14, pg 585, 2017) [J].
Claesson, Marcus J. ;
Clooney, Adam G. ;
O'Toole, Paul W. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (10) :585-595
[8]   PREVALENCE AND CONSISTENCY OF LOW BREATH H-2 EXCRETION FOLLOWING LACTULOSE INGESTION - POSSIBLE IMPLICATIONS FOR THE CLINICAL USE OF THE H-2 BREATH TEST [J].
CORAZZA, G ;
STROCCHI, A ;
SORGE, M ;
BENATI, G ;
GASBARRINI, G .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (11) :2010-2016
[9]   THE DIAGNOSIS OF SMALL-BOWEL BACTERIAL OVERGROWTH - RELIABILITY OF JEJUNAL CULTURE AND INADEQUACY OF BREATH HYDROGEN TESTING [J].
CORAZZA, GR ;
MENOZZI, MG ;
STROCCHI, A ;
RASCITI, L ;
VAIRA, D ;
LECCHINI, R ;
AVANZINI, P ;
CHEZZI, C ;
GASBARRINI, G .
GASTROENTEROLOGY, 1990, 98 (02) :302-309
[10]  
Di Stefano M, 2000, ALIMENT PHARM THERAP, V14, P551